TABLE 1.
Participant characteristics.
| Mean ± SD | |
| Demographics and Anthropometrics (n = 47) | |
| Age (years) | 57 ± 11 |
| Sex (% male) | 77 |
| Ethnicity (% white) | 85 |
| Height (cm) | 171.0 ± 9.6 |
| Body mass (kg) | 83.8 ± 16.0 |
| BMI (kg/m2) | 28.7 ± 5.2 |
| Waist circumference (cm) | 100.2 ± 12.7 |
| Resting systolic blood pressure (mmHg) | 120 ± 14 |
| Resting diastolic blood pressure (mmHg) | 73 ± 9 |
| Resting heart rate (bpm) | 68 ± 12 |
| Cardiovascular conditions (n = 47) | |
| Percutaneous coronary intervention, yes: no, n | 30:17 |
| STEMI, yes: no, n | 15:32 |
| Angiogram, yes: no, n | 11:36 |
| Non-STEMI, yes: no, n | 8:39 |
| Coronary artery bypass grafting surgery, yes: no, n | 7:40 |
| Angina, yes: no, n | 6:41 |
| Atrial fibrillation, yes: no, n | 5:42 |
| Previous myocardial infarction, yes: no, n | 2:45 |
| Mitral value surgery, yes: no, n | 2:45 |
| Aortic valve surgery, yes: no, n | 1:46 |
| Acute coronary syndrome, yes: no, n | 1:46 |
| Ablation, yes: no, n | 1:46 |
| Medications (n = 49) | |
| Anti-platelet, yes: no, n | 48:1 |
| Statins, yes: no, n | 41:8 |
| β-blocker, yes: no, n | 33:16 |
| ACE inhibitor, yes: no, n | 20:29 |
| Nitroglycerin, yes: no, n | 18:31 |
| Angiotensin II receptor antagonist, yes: no, n | 3:46 |
| Calcium channel blocker, yes: no, n | 3:46 |
| Thiazide diuretic, yes: no, n | 3:46 |
| PCSK9 inhibitor, yes: no, n | 1:48 |
ACE, angiotensin-converting enzyme; BMI, body mass index; ICD, implantable cardioverter-defibrillator; PCSK, proprotein convertase subtilisin/kexin; SD, standard deviation; STEMI, ST-elevation myocardial infarction.